Cargando…
Chemokine CCL20 promotes the paclitaxel resistance of CD44(+)CD117(+) cells via the Notch1 signaling pathway in ovarian cancer
Studies have found that C-C motif chemokine ligand 20 (CCL20)/C-C motif chemokine receptor 6 (CCR6)/notch receptor 1 (Notch1) signaling serves an important role in various diseases, but its role and mechanism in ovarian cancer remains to be elucidated. The aim of the present study was to investigate...
Autores principales: | Chen, Min, Su, Juan, Feng, Chunmei, Liu, Ying, Zhao, Li, Tian, Yongjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280726/ https://www.ncbi.nlm.nih.gov/pubmed/34278466 http://dx.doi.org/10.3892/mmr.2021.12274 |
Ejemplares similares
-
Another Notch in CD44
por: Dove, Alan W.
Publicado: (2001) -
Inhibitory effects of metformin at low concentration on epithelial–mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells
por: Zhang, Rongrong, et al.
Publicado: (2015) -
Targeting Ovarian Cancer Cells Overexpressing CD44 with Immunoliposomes Encapsulating Glycosylated Paclitaxel
por: Khayrani, Apriliana Cahya, et al.
Publicado: (2019) -
miR-26b regulates cell proliferation and apoptosis of CD117+CD44+ ovarian cancer stem cells by targeting PTEN
por: Gao, Zubiao, et al.
Publicado: (2021) -
CD117(+)CD44(+) Stem T Cells Develop in the Thymus and Potently Suppress T-cell Proliferation by Modulating the CTLA-4 Pathway
por: Wei, Yang, et al.
Publicado: (2017)